f8k_050213.htm
United States
Securities and Exchange Commission
Washington, D.C. 20549
 
 
FORM 8-K
 
 
Current Report Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
May 2, 2013
(Date of Report)
 
 
ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
000-20852
16-1387013
(State of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
2000 Technology Parkway, Newark, New York
14513
(Address of principal executive offices)
(Zip Code)
 
(315) 332-7100
(Registrant’s telephone number, including area code)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

 
Item 2.02
Results of Operation and Financial Condition.

NEWARK, N.Y. – May 2, 2013 -- Ultralife Corporation (NASDAQ: ULBI) reported an operating profit from continuing operations of $0.4 million on revenue of $21.0 million for the quarter ended March 31, 2013.  For the first quarter of 2012, the company reported an operating loss from continuing operations of $1.3 million on revenue of $27.5 million.

Discontinued operations for the first quarter of 2013 include the final settlement of our obligation to return our former UK facility back to its original condition per a previous contractual commitment.  For the first quarter of 2012 discontinued operations include the operating results of RedBlack which was sold in the third quarter of 2012.  All revenue, gross margin and operating expense amounts presented below represent results from continuing operations.

Revenue was $21.0 million, compared to $27.5 million for the first quarter of 2012, a 24% decline, reflecting an increase of $0.5 million in Communications Systems sales offset by a $7.0 million decrease in Battery & Energy Products sales.  As a result of continued new business development, the mix of sales from international customers increased to 46% from 37% for the first quarter last year. Battery & Energy Products sales were $13.1 million, compared to $20.1 million last year, a 35% decline, reflecting for the most part the continued slowdown in U.S. government and defense order rate for rechargeable and non-rechargeable batteries and charger systems.  Communications Systems sales were $8.0 million, compared to $7.4 million for the same period last year, an increase of 7%, reflecting the fulfillment of large orders for amplifiers from international defense customers and continued demand for amplifiers from the U.S. government.

Gross profit was $6.4 million, or 30.3% of revenue, compared to $6.6 million, or 24.0% of revenue, for the same quarter a year ago. The 630 basis point increase reflected productivity gains in both businesses and a higher mix of Communications Systems sales. Battery & Energy Products’ gross margin was 23.7%, compared to 19.6% last year, an increase of 410 basis points due to productivity improvements resulting from our lean processes and improved 9-volt margins which partially offset lower overhead absorption on volume declines. Communications Systems’ gross margin was 41.2%, an increase of 550 basis points over the 35.7% gross margin reported last year, which resulted from higher volumes and productivity improvements.

Operating expenses decreased by 24% to $6.0 million, compared to $7.9 million a year ago, reflecting across-the-board actions taken to align spending with revenue.  As a result, operating expenses were 28.6% of revenue, compared to 28.7% for the year earlier period.

The combination of higher gross margin and essentially flat operating expenses as a percentage of revenue resulted in a $1.7 million improvement in operating income to $0.4 million, compared to an operating loss of $1.3 million last year, despite lower revenue.  Operating margin for the first quarter of 2013 was 1.8%.

Net income from continuing operations was $0.2 million, or $0.01 per share, compared to a net loss of $1.4 million, or $0.08 per share, for the first quarter of 2012.  Net income from discontinued operations was $0.3 million, or $0.02 per share, for the first quarter of 2013 versus a net loss of $.1 million, or $0.01 per share, for the first quarter of 2012.

The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed to be incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.
 
Item 9.01
Financial Statements, Pro Forma Financials and Exhibits.

(a)  
Exhibits

99.1 Press Release of Ultralife Corporation dated May 2, 2013

 
 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:  May 2, 2013
 
ULTRALIFE CORPORATION
     
 
By:
/s/ Philip A. Fain
   
Philip A. Fain
   
Chief Financial Officer & Treasurer
     










 
 

 
EXHIBIT INDEX
 
Exhibit
Number
  Description
     
99.1
 
Press Release of Ultralife Corporation dated May 2, 2013
 
exh_991.htm
Exhibit 99.1
 
Company Contact:   Investor Relations Contact:
Ultralife Corporation   Lippert/Heilshorn & Associates
Philip Fain   Jody Burfening
(315) 332-7100   (212) 838-3777
pfain@ulbi.com   jburfening@lhai.com
 
Ultralife Corporation Reports First Quarter Results


NEWARK, N.Y. – May 2, 2013 -- Ultralife Corporation (NASDAQ: ULBI) reported an operating profit from continuing operations of $0.4 million on revenue of $21.0 million for the quarter ended March 31, 2013.  For the first quarter of 2012, the company reported an operating loss from continuing operations of $1.3 million on revenue of $27.5 million.

“Through solid execution in the face of ongoing softness in our Battery & Energy Products business, we delivered our third consecutive profitable quarter, consistent with our internal expectations, and reversed last year’s operating loss,” said Michael D. Popielec, Ultralife’s president and chief executive officer.   “Despite the budget pressures confronted by our U.S. government/defense customers, our plans to diversify our revenue by driving international and commercial opportunities are proceeding, and we are still planning for modest revenue gains in our Battery & Energy Products business in 2013. Revenue for our Communications Systems business grew by 7% and we expect year-over-year growth to continue throughout 2013 based on our opportunity funnel and anticipated timing of pending projects.  As a result, with an efficient and profitable business model and strong cash generation, we remain well positioned to realize operating leverage gains on revenue growth during 2013.”

First Quarter 2013 Financial Results

Discontinued operations for the first quarter of 2013 include the final settlement of our obligation to return our former UK facility back to its original condition per a previous contractual commitment.  For the first quarter of 2012 discontinued operations include the operating results of RedBlack which was sold in the third quarter of 2012.  All revenue, gross margin and operating expense amounts presented below represent results from continuing operations.

Revenue was $21.0 million, compared to $27.5 million for the first quarter of 2012, a 24% decline, reflecting an increase of $0.5 million in Communications Systems sales offset by a $7.0 million decrease in Battery & Energy Products sales.  As a result of continued new business development, the mix of sales from international customers increased to 46% from 37% for the first quarter last year. Battery & Energy Products sales were $13.1 million, compared to $20.1 million last year, a 35% decline, reflecting for the most part the continued slowdown in U.S. government and defense order rate for rechargeable and non-rechargeable batteries and charger systems.  Communications Systems sales were $8.0 million, compared to $7.4 million for the same period last year, an increase of 7%, reflecting the fulfillment of large orders for amplifiers from international defense customers and continued demand for amplifiers from the U.S. government.

Gross profit was $6.4 million, or 30.3% of revenue, compared to $6.6 million, or 24.0% of revenue, for the same quarter a year ago. The 630 basis point increase reflected productivity gains in both businesses and a higher mix of Communications Systems sales. Battery & Energy Products’ gross margin was 23.7%, compared to 19.6% last year, an increase of 410 basis points due to productivity improvements resulting from our lean processes and improved 9-volt margins which partially offset lower overhead absorption on volume declines. Communications Systems’ gross margin was 41.2%, an increase of 550 basis points over the 35.7% gross margin reported last year, which resulted from higher volumes and productivity improvements.

Operating expenses decreased by 24% to $6.0 million, compared to $7.9 million a year ago, reflecting across-the-board actions taken to align spending with revenue.  As a result, operating expenses were 28.6% of revenue, compared to 28.7% for the year earlier period.

The combination of higher gross margin and essentially flat operating expenses as a percentage of revenue resulted in a $1.7 million improvement in operating income to $0.4 million, compared to an operating loss of $1.3 million last year, despite lower revenue.  Operating margin for the first quarter of 2013 was 1.8%.

Net income from continuing operations was $0.2 million, or $0.01 per share, compared to a net loss of $1.4 million, or $0.08 per share, for the first quarter of 2012.  Net income from discontinued operations was $0.3 million, or $0.02 per share, for the first quarter of 2013 versus a net loss of $.1 million, or $0.01 per share, for the first quarter of 2012.

Outlook

Management reiterated its outlook for 2013 and continues to expect low- to mid-single digit revenue growth reflecting strong growth in Communications Systems sales and modest gains in the Battery & Energy Products business, despite continued constraints on U.S. government spending.  Based on this outlook for revenue growth, ongoing productivity improvements and plans to continue prudently investing in new product development, management expects to increase operating profitability for the year and to generate a mid-single digit operating margin.

Management cautions that the timing of orders and shipments may cause variability in quarterly results.

About Ultralife Corporation
 
Ultralife Corporation serves its markets with products and services ranging from portable power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorp.com.

Conference Call Information

Ultralife will hold its first quarter earnings conference call today at 10:00 AM ET. To participate, please call (800) 915-4836, identify yourself and ask for the Ultralife call. The conference call will also be broadcast live over the Internet in the Events & Presentations section of the company’s website at http://investor.ultralifecorporation.com. To listen to the call, please go to the web site at least fifteen minutes early to download and install any necessary audio software. For those who cannot listen to the live webcast, a replay of the webcast will be available shortly after the call at the same location.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include:  potential reductions in U.S. military spending, uncertain global economic conditions and acceptance of our new products on a global basis. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

 
 

 
ULTRALIFE CORPORATION
 CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Per Share Amounts)
(unaudited)
 
   
March 31,
   
December 31,
 
ASSETS
 
2013
   
2012
 
             
Current assets:
           
Cash and cash equivalents
  $ 8,908     $ 10,078  
Trade accounts receivable, net
    17,280       20,913  
Inventories
    28,281       30,370  
Prepaid expenses and other current assets
    2,570       2,461  
Total current assets
    57,039       63,822  
                 
Property and equipment
    11,778       12,415  
                 
Other assets:
               
Goodwill, intangible and other assets
    23,425       21,481  
                 
Total Assets
  $ 92,242     $ 97,718  
                 
LIABILITIES AND SHAREHOLDERS' EQUITY
               
                 
Current liabilities:
               
Short-term debt and current portion of long-term debt
  $ -     $ -  
Accounts payable
    8,710       11,357  
Other current liabilities
    5,072       8,535  
Total current liabilities
    13,782       19,892  
                 
Long-term liabilities:
               
Other long-term liabilities
    4,506       4,370  
                 
Shareholders' equity:
               
Ultralife equity:
               
Common stock, par value $0.10 per share
    1,886       1,886  
Capital in excess of par value
    173,993       173,791  
Accumulated other comprehensive loss
    (747 )     (620 )
Accumulated deficit
    (93,449 )     (93,878 )
 
    81,683       81,179  
Less -- Treasury stock, at cost
    7,658       7,658  
Total Ultralife equity
    74,025       73,521  
Noncontrolling interest
    (71 )     (65 )
Total shareholders' equity
    73,954       73,456  
                 
Total Liabilities and Shareholders' Equity
  $ 92,242     $ 97,718  
 
 
 

 
ULTRALIFE CORPORATION
 
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 
(In Thousands, Except Per Share Amounts)
 
(Unaudited)
 
   
   
   
   
Three-Month Periods Ended
 
             
   
March 31,
   
April 1,
 
   
2013
   
2012
 
             
Revenues:
           
Battery & energy products
  $ 13,053     $ 20,082  
Communications systems
    7,966       7,419  
Total revenues
    21,019       27,501  
                 
Cost of products sold:
               
Battery & energy products
    9,953       16,139  
Communications systems
    4,687       4,769  
Total cost of products sold
    14,640       20,908  
                 
Gross profit
    6,379       6,593  
                 
Operating expenses:
               
Research and development
    1,369       2,139  
Selling, general, and administrative
    4,635       5,743  
Total operating expenses
    6,004       7,882  
                 
Operating income (loss)
    375       (1,289 )
                 
Other income (expense):
               
Interest income
    2       1  
Interest expense
    (90 )     (104 )
Miscellaneous
    (25 )     52  
Income (loss) from continuing operations before income taxes
    262       (1,340 )
 
               
Income tax provision-current
    38       79  
Income tax provision-deferred
    60       12  
Total income taxes
    98       91  
                 
Net income (loss) from continuing operations
    164       (1,431 )
                 
Discontinued operations:
               
Income (loss) from discontinued operations, net of tax
    264       (71 )
                 
Net income (loss)
    428       (1,502 )
                 
Net (income) loss attributable to noncontrolling interest
    6       -  
                 
Net income (loss) attributable to Ultralife
  $ 434     $ (1,502 )
                 
Other comprehensive income (loss):
               
Foreign currency translation adjustments
    (127 )     148  
                 
Comprehensive income (loss) attributable to Ultralife
  $ 307     $ (1,354 )
                 
                 
Net income (loss) attributable to Ultralife common shareholders - basic
         
Continuing operations
  $ 0.01     $ (0.08 )
Discontinued operations
  $ 0.02     $ (0.01 )
Total
  $ 0.02     $ (0.09 )
Net income (loss) attributable to Ultralife common shareholders - diluted
         
Continuing operations
  $ 0.01     $ (0.08 )
Discontinued operations
  $ 0.02     $ (0.01 )
Total
  $ 0.02     $ (0.09 )
                 
                 
Weighted average shares outstanding - basic
    17,457       17,358  
Weighted average shares outstanding - diluted
    17,478       17,358